Jeffrey A. Spaeder, M.D., has been appointed chief medical and scientific officer at Quintiles. He succeeds Dr. Oren Cohen who now leads Quintiles’ Phase I clinical research business. Dr. Spaeder will serve as lead medical expert, representing the company on a variety of governance, ethical and scientific issues. He will provide leadership in the ethical conduct of studies and provide guidance on strategic scientific initiatives. Dr. Spaeder will also chair Quintiles’ Drug Safety Committee and ...